Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance.
Sgherza N, Di Gennaro D, Curci P, Rizzi R, Roccotelli D, Croce M, Avantaggiato M, Ruga L, Strafella V, Vitucci A, Palma A, Russo Rossi AV, Troiano T, Larocca AMV, Chironna M, Tafuri S, Albano F, Musto P. Sgherza N, et al. Among authors: di gennaro d. Hemasphere. 2022 Nov 9;6(12):e800. doi: 10.1097/HS9.0000000000000800. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36382051 Free PMC article. No abstract available.
Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience.
Delia M, Gagliardi VP, Carluccio P, Attolico I, Contento C, Di Gennaro D, Albano F, Musto P. Delia M, et al. Among authors: di gennaro d. Leuk Res. 2023 Jun;129:107069. doi: 10.1016/j.leukres.2023.107069. Epub 2023 Mar 24. Leuk Res. 2023. PMID: 37019049 No abstract available.
Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study.
Sgherza N, Curci P, Rizzi R, Strafella V, Di Gennaro D, Vitucci A, Palma A, Rossi AVR, Albano F, Stefanizzi P, Tafuri S, Musto P. Sgherza N, et al. Among authors: di gennaro d. Haematologica. 2022 Feb 1;107(2):555-557. doi: 10.3324/haematol.2021.279895. Haematologica. 2022. PMID: 34732044 Free PMC article. No abstract available.
Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients.
Sgherza N, Zucano S, Vitucci A, Palma A, Tarantini F, Campanale D, Vimercati L, Larocca AMV, Visceglie D, Acquafredda A, Ostuni A, Di Gennaro D, Vitucci C, Tafuri S, Musto P. Sgherza N, et al. Among authors: di gennaro d. Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022056. doi: 10.4084/MJHID.2022.056. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35865398 Free PMC article. No abstract available.